Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Pinar G. Ozdemir, Aysel Milanlioglu, Murat Boysan, Vedat Cilingir, Nuri Aydin & Abdullah Atli. (2015) Relations between mood characteristics, circadian preferences, and functionality in multiple sclerosis. International Journal of Psychiatry in Clinical Practice 19:2, pages 148-154.
Read now
Read now
Korinna Karampampa, Anders Gustavsson, Erik Th. L. van Munster, Raymond M. M. Hupperts, Evert A. C. M. Sanders, Jop Mostert, Okke L. G. F. Sinnige, Jaap de Graaf, Paul Pop, Carolin Miltenburger, Martijn T. Groot, Milon Relleke & W. S. van der Hel. (2013) Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands. Journal of Medical Economics 16:7, pages 939-950.
Read now
Read now
Elisa Picardo, Emilie Marion Canuto, Luca Marozio & Chiara Benedetto. (2013) Multiple sclerosis and pregnancy. Expert Review of Obstetrics & Gynecology 8:3, pages 223-234.
Read now
Read now
Kenneth P Johnson. (2012) Glatiramer acetate for treatment of relapsing–remitting multiple sclerosis. Expert Review of Neurotherapeutics 12:4, pages 371-384.
Read now
Read now
Articles from other publishers (57)
Saeed Akhtar, Jasem Y. Al-Hashel & Raed Alroughani. (2023) Impact of the first Gulf war on multiple sclerosis risk in Kuwait: a quasi-experimental study. BMC Neurology 23:1.
Crossref
Crossref
Begimai Kadyrova, Asel Jusupova, Nurzhan Dzhaparalieva & Bolot Kulov. (2023) Influence of mountain climate on multiple sclerosis. Heart, Vessels and Transplantation 0:Ahead of Print.
Crossref
Crossref
Giorgia Teresa Maniscalco, Cristina Scavone, Annamaria Mascolo, Valentino Manzo, Elio Prestipino, Gaspare Guglielmi, Maria Luisa Aiezza, Santolo Cozzolino, Adele Bracco, Ornella Moreggia, Daniele Di Giulio Cesare, Antonio Rosario Ziello, Angela Falco, Marida Massa, Massimo Majolo, Eliana Raiola, Roberto Soprano, Giuseppe Russo, Giuseppe Longo, Vincenzo Andreone & Annalisa Capuano. (2022) The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study. Journal of Clinical Medicine 11:22, pages 6855.
Crossref
Crossref
Maria Lima, Athina-Maria Aloizou, Vasileios Siokas, Christos Bakirtzis, Ioannis Liampas, Zisis Tsouris, Dimitrios P. Bogdanos, Stavros J. Baloyannis & Efthimios Dardiotis. (2022) Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia?. Reviews in the Neurosciences 33:7, pages 703-720.
Crossref
Crossref
Mohammad Javad Mohammadi, Kourosh Zarea, Nasser Hatamzadeh, Arash Salahshouri & Asaad Sharhani. (2022) Toxic Air Pollutants and Their Effect on Multiple Sclerosis: A Review Study. Frontiers in Public Health 10.
Crossref
Crossref
Aleksandar Stojanov & Jelena Stojanov. (2022) Depression as a determinant of quality of life in patients with multiple sclerosis. Galenika Medical Journal 1:3, pages 22-27.
Crossref
Crossref
Borros M Arneth. (2023) Pregnancy in Patients with Multiple Sclerosis. Journal of Investigative Medicine 70:1, pages 14-19.
Crossref
Crossref
Eva Costa-Arpín, Begoña Ares, Arturo González-Quintela & José Prieto-González. (2021) Temporal trends in the incidence and prevalence of Multiple Sclerosis in the Northwest of Spain. Multiple Sclerosis and Related Disorders 52, pages 102979.
Crossref
Crossref
Bahar ALKAYA, Mustafa ÖZCAN, Mehmet Cenk HAYTAÇ, Meltem DEMİRKIRAN & Mehmet BALAL. (2021) Multiple skleroz ile periodontal sağlık arasındaki ilişki: klinik- immunolojik çalışmaThe relationship between multiple sclerosis and periodontal health: a clinical-immunological study. Cukurova Medical Journal 46:2, pages 436-442.
Crossref
Crossref
Katerina Dadouli, Panagiotis Ntellas, Lemonia Anagnostopoulos, Konstantinos Bonotis, Efthimios Dardiotis & Christos Hadjichristodoulou. (2021) Geography of hospital admissions for multiple sclerosis in Greece. Multiple Sclerosis and Related Disorders 49, pages 102735.
Crossref
Crossref
Giorgia Maniscalco, Vincenzo Brescia Morra, Ciro Florio, Giacomo Lus, Gioacchino Tedeschi, Maddalena Cianfrani, Renato Docimo, Stefania Miniello, Felice Romano, Leonardo Sinisi, Daniele Spitaleri, Giuseppe Longo, Ugo Trama, Maria Triassi, Cristina Scavone & Annalisa Capuano. (2020) Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project. Pharmaceuticals 13:12, pages 466.
Crossref
Crossref
Mariana Branco, Ivânia Alves, Ana Martins da Silva, Joaquim Pinheiro, Maria José Sá, Inês Correia, Lívia Sousa, Eva Brandão, Carlos Veira, Bernardo Gomes & Luis Ruano. (2020) The epidemiology of multiple sclerosis in the entre Douro e Vouga region of northern Portugal: a multisource population-based study. BMC Neurology 20:1.
Crossref
Crossref
Francesco Corallo, Lilla Bonanno, Marcella Di Cara, Carmela Rifici, Edoardo Sessa, GianGaetano D’Aleo, Viviana Lo Buono, Giuseppe Venuti, Placido Bramanti & Silvia Marino. (2019) Therapeutic adherence and coping strategies in patients with multiple sclerosis. Medicine 98:29, pages e16532.
Crossref
Crossref
Marcella Di Cara, Viviana Lo Buono, Francesco Corallo, Cecilia Cannistraci, Carmela Rifici, Edoardo Sessa, Giangaetano D’Aleo, Placido Bramanti & Silvia Marino. (2019) Body image in multiple sclerosis patients: a descriptive review. Neurological Sciences 40:5, pages 923-928.
Crossref
Crossref
José de Jesús Guerrero-García, Marisol Godínez-Rubí & Daniel Ortuño-Sahagún. (2018) Multiple Sclerosis in Search for Biomarkers: Gender as a Variable in the Equation. Advances in Neuroimmune Biology 7:1, pages 43-54.
Crossref
Crossref
Jian Zhang, Shengliang Shi, Yueling Zhang, Jiefeng Luo, Yousheng Xiao, Lian Meng & Xiaobo Yang. (2017) alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis. Cochrane Database of Systematic Reviews 2018:5.
Crossref
Crossref
Emine Nur ÖZDAMAR, Ahmet AKICI, Ali ALKAN, Banu BAYAR & Hakkı GÜRSÖZ. (2017) A nationwide evaluation of off-label drug utilization in Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES 47, pages 1229-1238.
Crossref
Crossref
Waldemar Brola, Piotr Sobolewski, Stanisław Flaga, Małgorzata Fudala, Wiktor Szczuchniak, Jan Stoiński, Anita Rosołowska, Jacek Wójcik, Katarzyna Kapica-Topczewska & Danuta Ryglewicz. (2016) Prevalence and incidence of multiple sclerosis in central Poland, 2010–2014. BMC Neurology 16:1.
Crossref
Crossref
Stephen Montgomery, Jeanette Kusel, Felicity Allen & Nicholas Adlard. (2016) Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK. Applied Health Economics and Health Policy 14:5, pages 545-558.
Crossref
Crossref
V. Passananti, A. Wilton, G. Preziosi, J. B. Storrie & A. Emmanuel. (2016) Long-term efficacy and safety of transanal irrigation in multiple sclerosis. Neurogastroenterology & Motility 28:9, pages 1349-1355.
Crossref
Crossref
Loredana La Mantia, Irene Tramacere, Belal Firwana, Ilaria Pacchetti, Roberto Palumbo & Graziella Filippini. (2016) Fingolimod for relapsing-remitting multiple sclerosis. Cochrane Database of Systematic Reviews 2016:4.
Crossref
Crossref
Fatemeh Moghaddam Tabrizi & Moloud Radfar. (2015) Fatigue, Sleep Quality, and Disability in Relation to Quality of Life in Multiple Sclerosis. International Journal of MS Care 17:6, pages 268-274.
Crossref
Crossref
Alison Leary, Geraldine MynorsAmy Bowen. (2015) Modelling the complex activity of multiple sclerosis specialist nurses in England. British Journal of Neuroscience Nursing 11:4, pages 170-176.
Crossref
Crossref
Alison Leary, Debbie Quinn & Amy Bowen. (2015) Impact of Proactive Case Management by Multiple Sclerosis Specialist Nurses on Use of Unscheduled Care and Emergency Presentation in Multiple Sclerosis. International Journal of MS Care 17:4, pages 159-163.
Crossref
Crossref
Zhou Liu, Bing He, Rong-Yi Zhang, Ke Zhang, Ying Ding, Jing-Wen Ruan, Eng-Ang Ling, Jin-Lang Wu & Yuan-Shan Zeng. (2015) Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Preinduced with Neurotrophin-3 and Retinoic Acid into Oligodendrocyte-Like Cells in Demyelinated Spinal Cord of Rats. Cell Transplantation 24:7, pages 1265-1281.
Crossref
Crossref
Guillermo Izquierdo, Nuria García-Agua Soler, Macarena Rus & Antonio José García-Ruiz. (2015) Effectiveness of glatiramer acetate compared to other multiple sclerosis therapies. Brain and Behavior 5:6, pages n/a-n/a.
Crossref
Crossref
A. Saiz, S. Mora & J. Blanco. (2015) Treatment compliance with first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study. Neurología (English Edition) 30:4, pages 214-222.
Crossref
Crossref
A. Saiz, S. Mora & J. Blanco. (2015) Cumplimiento terapéutico con terapias modificadoras de la enfermedad de primera línea en pacientes con esclerosis múltiple. Estudio COMPLIANCE. Neurología 30:4, pages 214-222.
Crossref
Crossref
L. Piccolo, G. Kumar, I. Nakashima, T. Misu, Y. Kong, B. Wakerley, S. Ryan, A. Cavey, K. Fujihara & Jacqueline Palace. (2015) Multiple sclerosis in Japan appears to be a milder disease compared to the UK. Journal of Neurology 262:4, pages 831-836.
Crossref
Crossref
Nikolaos E. Bechrakis, Philip J. Luthert & David J. Wilson. 2015. Eye Pathology. Eye Pathology
307
401
.
Ariane Höer, Guido Schiffhorst, Anne Zimmermann, Johann Fischaleck, Luise Gehrmann, Henrik Ahrens, Gunther Carl, Karl-Otto Sigel, Ulrike Osowski, Maria Klein & Hans-Holger Bleß. (2014) Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system. BMC Health Services Research 14:1.
Crossref
Crossref
Elisabeth Anens, Margareta Emtner, Lena Zetterberg & Karin Hellström. (2014) Physical activity in subjects with multiple sclerosis with focus on gender differences: a survey. BMC Neurology 14:1.
Crossref
Crossref
Robert J Simpson, Gary McLean, Bruce Guthrie, Frances Mair & Stewart W Mercer. (2014) Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis. BMC Neurology 14:1.
Crossref
Crossref
Carmen Arnal-García, Maria del Campo Amigo-Jorrin, Ana Maria López-Real, Carme Lema-Devesa, Noemi Llopis & R. Sanchez-de la Rosa. (2014) Long-term effectiveness of glatiramer acetate in clinical practice conditions. Journal of Clinical Neuroscience 21:12, pages 2212-2218.
Crossref
Crossref
V. Zsiros, Z. Fricska-Nagy, J. Füvesi, Z. T. Kincses, É. Langane, E. Paulik, L. Vécsei & K. Bencsik. (2014) Prevalence of multiple sclerosis in Csongrád County, Hungary. Acta Neurologica Scandinavica 130:5, pages 277-282.
Crossref
Crossref
Ching-Piao Tsai, Feng-Cheng Lin & Charles Tzu-Chi Lee. (2014) Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study. Multiple Sclerosis Journal 20:12, pages 1593-1601.
Crossref
Crossref
Nadja Borisow, Friedemann Paul, Stephanie Ohlraun, Daniel Pach, Felix Fischer & Jan Dörr. (2014) Pregnancy in Multiple Sclerosis: A Questionnaire Study. PLoS ONE 9:6, pages e99106.
Crossref
Crossref
Jian Zhang, Yousheng Xiao, Lian Meng, Xiaobo Yang & Shengliang Shi. (2014) Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Elaine Kingwell, James J Marriott, Nathalie Jetté, Tamara Pringsheim, Naila Makhani, Sarah A Morrow, John D Fisk, Charity Evans, Sarah Gabrielle Béland, Sophie Kulaga, Jonathan Dykeman, Christina Wolfson, Marcus W Koch & Ruth Ann Marrie. (2013) Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurology 13:1.
Crossref
Crossref
Ching-Piao Tsai & Charles Tzu-Chi Lee. (2013) Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997–2008. Clinical Drug Investigation 33:9, pages 647-652.
Crossref
Crossref
L. Skovgaard, P.H. Nicolajsen, E. Pedersen, M. Kant, S. Fredrikson, M. Verhoef & D.W. Meyrowitsch. (2013) People with multiple sclerosis in Denmark who use complementary and alternative medicine—Do subgroups of patients differ?. European Journal of Integrative Medicine 5:4, pages 365-373.
Crossref
Crossref
Ching-Piao Tsai & Charles Tzu-Chi Lee. (2013) Multiple Sclerosis Incidence Associated with the Soil Lead and Arsenic Concentrations in Taiwan. PLoS ONE 8:6, pages e65911.
Crossref
Crossref
Ernesto Ojeda, Diana Díaz-Cortes, Dominique Rosales, Carolina Duarte-Rey, Juan-Manuel Anaya & Adriana Rojas-Villarraga. (2013) Prevalence and clinical features of multiple sclerosis in Latin America. Clinical Neurology and Neurosurgery 115:4, pages 381-387.
Crossref
Crossref
Emily J. Hadgkiss, George A. Jelinek, Tracey J. Weiland, Greg Rumbold, Claire A. Mackinlay, Siegfried Gutbrod & Ian Gawler. (2012) Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis. Neurological Sciences 34:2, pages 187-195.
Crossref
Crossref
Nadja Borisow, Andrea Döring, Caspar F Pfueller, Friedemann Paul, Jan Dörr & Kerstin Hellwig. (2012) Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy. EPMA Journal 3:1.
Crossref
Crossref
Hideki Houzen, Masaaki Niino, Makoto Hirotani, Toshiyuki Fukazawa, Seiji Kikuchi, Keiko Tanaka & Hidenao Sasaki. (2012) Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan. Journal of the Neurological Sciences 323:1-2, pages 117-122.
Crossref
Crossref
Maria Skokou, Evanthia Soubasi & Philippos Gourzis. (2012) Depression in Multiple Sclerosis: A Review of Assessment and Treatment Approaches in Adult and Pediatric Populations. ISRN Neurology 2012, pages 1-6.
Crossref
Crossref
F. Mattioli, C. Stampatori, C. Scarpazza, G. Parrinello & R. Capra. (2012) Persistence of the effects of attention and executive functions intensive rehabilitation in relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 1:4, pages 168-173.
Crossref
Crossref
Korinna Karampampa, Anders Gustavsson, Carolin Miltenburger & Benjamin Eckert. (2012) Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries. Multiple Sclerosis Journal 18:2_suppl, pages 7-15.
Crossref
Crossref
U. Mehnert & M. Nehiba. (2012) Neurourologische Funktionsstörungen des unteren Harntraktes bei Erkrankungen des ZNSNeuro-urological dysfunction of the lower urinary tract in CNS diseases. Der Urologe 51:2, pages 189-197.
Crossref
Crossref
L. Skovgaard, P. H. Nicolajsen, E. Pedersen, M. Kant, S. Fredrikson, M. Verhoef & D. W. Meyrowitsch. (2012) Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries. Autoimmune Diseases 2012, pages 1-13.
Crossref
Crossref
M. Shirzadi, S. Alvestad, H. Hovdal, K. Espeset, S. Lydersen & E. Brodtkorb. (2012) Comparison of carbamazepine rash in multiple sclerosis and epilepsy. Acta Neurologica Scandinavica 125:1, pages 60-63.
Crossref
Crossref
Dian He, Hongyu Zhou, Wenjie Han & Shihong Zhang. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Marc P. Hübner, David Larson, Marina N. Torrero, Ellen Mueller, Yinghui Shi, Kristin E. Killoran & Edward Mitre. (2011) Anti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice. Clinical Immunology 141:2, pages 205-217.
Crossref
Crossref
Dian He, Hongyu Zhou, Wenjie Han & Shihong Zhang. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Zinat Miabi, Mehran Midia, Ramin Midia & Dariush Moghinan. (2010) Anatomical Distribution of Central Nervous System Plaques in Multiple Sclerosis: An Iranian Experience. Pakistan Journal of Biological Sciences 13:24, pages 1195-1201.
Crossref
Crossref
F. V. Bahinski, N. V. Galinovskaja, N. N. Usova, V. O. Demidova & V. Ja. Latysheva. (2010) MULTIPLE SCLEROSIS: MODERN VIEW ON THE PROBLEM (literature review). Health and Ecology Issues:3, pages 75-80.
Crossref
Crossref